Maryland Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Maryland Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$500	Hold	8	–	–	﹤0.01%	282
2026 Q2	$461	Buy	+8	New	+$459	﹤0.01%	289
2024 Q1	–	Sell	-200	Closed	-$10.3K	–	223
2023 Q4	$10.3K	Hold	200	–	–	0.01%	172
2023 Q3	$11.6K	Hold	200	–	–	0.01%	167
2023 Q2	$12.8K	Hold	200	–	–	0.01%	168
2023 Q1	$13.9K	Hold	200	–	–	0.01%	163
2022 Q4	$14.4K	Hold	200	–	–	0.01%	161
2022 Q3	$14K	Hold	200	–	–	0.01%	148
2022 Q2	$15K	Buy	+200	New	+$15.2K	0.02%	147

Other funds holding BMY

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

VFM

Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return

Maryland Capital Advisors's BMY Position: Q3 2026 in Review

Maryland Capital Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 8 shares worth $500. The position accounts for ﹤0.01% of the portfolio, ranked #282.

Maryland Capital Advisors first reported a position in BMY in Q2 2022 and has held it in 9 quarters since. The position peaked at $15K in Q2 2022. 340 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Maryland Capital Advisors held 8 shares of Bristol-Myers Squibb worth $500 as of Q3 2026.
Maryland Capital Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2026.
Bristol-Myers Squibb made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q3 2026, its #282 holding.
Maryland Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 9 quarters since.
Maryland Capital Advisors's Bristol-Myers Squibb position peaked at $15K in Q2 2022.
340 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Maryland Capital Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.